filings.toolsItem 1A. Risk Factors
2K characters. Original on sec.gov · Markdown
Item 1A. Risk Factors
There have been no material changes in our risk factors disclosed in Part 1, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended June 30, 2022.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Issuer Purchases of Equity Securities
| Total Number of Shares Purchased (1) | Average Price Paid per Share | Total Number of Shares Purchased as Part of the Publicly Announced Common Stock Repurchase Plan (2) | Maximum Approximate Dollar Value of Shares that may yet be Purchased under the Common Stock Repurchase Plan (2) | |||||||||||||||||||||||
| Period | ||||||||||||||||||||||||||
| July 1 to 31, 2022 | 697,683 | $ | 216.74 | 696,317 | $ | 954,803,421 | ||||||||||||||||||||
| August 1 to 31, 2022 | 359,839 | $ | 251.38 | 359,743 | $ | 864,371,104 | ||||||||||||||||||||
| September 1 to 30, 2022 | 662,324 | $ | 230.90 | 357,599 | $ | 780,366,639 | ||||||||||||||||||||
| Total | 1,719,846 | 1,413,659 |
(1) During the three months ended September 30, 2022, pursuant to the terms of our restricted stock program, the Company purchased 306,187 shares at the then-market value of the shares to satisfy certain tax withholding requirements for employees upon the vesting of their restricted shares.
(2) The Company received the Board of Directors' approval to repurchase the shares of our common stock included in the table above as follows:
| Date of Approval | |||||
| November 2019 | $5 billion |
There is no expiration date for the common stock repurchase authorization.
Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits